Michael A. DesJardin - Mar 2, 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role: EVP, Technical Operations
Signature: /s/ Miles W. McHugh, Attorney-in-Fact
Stock symbol: HZNP
Transactions as of: Mar 2, 2022
Transactions value $: -$3,401,752
Form type: 4
Date filed: 3/4/2022, 03:19 PM
Previous filing: Jan 24, 2022
Next filing: Apr 14, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HZNP	Ordinary Shares	Sale	-$2.08M	-21.5K	-15.62%	$97.05	116K	Mar 2, 2022	Direct	F1
transaction	HZNP	Ordinary Shares	Sale	-$1.32M	-13.5K	-11.65%	$97.42	103K	Mar 2, 2022	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.24 to $97.24 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.26 to $97.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.24 to $97.24 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.26 to $97.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.